Cargando…
Comments on “To clarify the safety profile of paracetamol for home-care patients with COVID-19: a real-world cohort study, with nested case–control analysis, in primary care”
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9830597/ https://www.ncbi.nlm.nih.gov/pubmed/36626015 http://dx.doi.org/10.1007/s11739-023-03194-y |
_version_ | 1784867700392067072 |
---|---|
author | Chirumbolo, Salvatore Valdenassi, Luigi Simonetti, Vincenzo Pandolfi, Sergio |
author_facet | Chirumbolo, Salvatore Valdenassi, Luigi Simonetti, Vincenzo Pandolfi, Sergio |
author_sort | Chirumbolo, Salvatore |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-9830597 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Springer International Publishing |
record_format | MEDLINE/PubMed |
spelling | pubmed-98305972023-01-10 Comments on “To clarify the safety profile of paracetamol for home-care patients with COVID-19: a real-world cohort study, with nested case–control analysis, in primary care” Chirumbolo, Salvatore Valdenassi, Luigi Simonetti, Vincenzo Pandolfi, Sergio Intern Emerg Med Ce - Letter to the Editor Springer International Publishing 2023-01-10 2023 /pmc/articles/PMC9830597/ /pubmed/36626015 http://dx.doi.org/10.1007/s11739-023-03194-y Text en © The Author(s), under exclusive licence to Società Italiana di Medicina Interna (SIMI) 2023 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
spellingShingle | Ce - Letter to the Editor Chirumbolo, Salvatore Valdenassi, Luigi Simonetti, Vincenzo Pandolfi, Sergio Comments on “To clarify the safety profile of paracetamol for home-care patients with COVID-19: a real-world cohort study, with nested case–control analysis, in primary care” |
title | Comments on “To clarify the safety profile of paracetamol for home-care patients with COVID-19: a real-world cohort study, with nested case–control analysis, in primary care” |
title_full | Comments on “To clarify the safety profile of paracetamol for home-care patients with COVID-19: a real-world cohort study, with nested case–control analysis, in primary care” |
title_fullStr | Comments on “To clarify the safety profile of paracetamol for home-care patients with COVID-19: a real-world cohort study, with nested case–control analysis, in primary care” |
title_full_unstemmed | Comments on “To clarify the safety profile of paracetamol for home-care patients with COVID-19: a real-world cohort study, with nested case–control analysis, in primary care” |
title_short | Comments on “To clarify the safety profile of paracetamol for home-care patients with COVID-19: a real-world cohort study, with nested case–control analysis, in primary care” |
title_sort | comments on “to clarify the safety profile of paracetamol for home-care patients with covid-19: a real-world cohort study, with nested case–control analysis, in primary care” |
topic | Ce - Letter to the Editor |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9830597/ https://www.ncbi.nlm.nih.gov/pubmed/36626015 http://dx.doi.org/10.1007/s11739-023-03194-y |
work_keys_str_mv | AT chirumbolosalvatore commentsontoclarifythesafetyprofileofparacetamolforhomecarepatientswithcovid19arealworldcohortstudywithnestedcasecontrolanalysisinprimarycare AT valdenassiluigi commentsontoclarifythesafetyprofileofparacetamolforhomecarepatientswithcovid19arealworldcohortstudywithnestedcasecontrolanalysisinprimarycare AT simonettivincenzo commentsontoclarifythesafetyprofileofparacetamolforhomecarepatientswithcovid19arealworldcohortstudywithnestedcasecontrolanalysisinprimarycare AT pandolfisergio commentsontoclarifythesafetyprofileofparacetamolforhomecarepatientswithcovid19arealworldcohortstudywithnestedcasecontrolanalysisinprimarycare |